Xin Hua Wang·2025-11-09 12:09Core Insights - The article highlights the dual approach of global and local innovation showcased at the 8th China International Import Expo, particularly through the lens of Fosun Pharma's exhibition [1][2] - Fosun Pharma's products, such as the Marie upright particle therapy system, are designed to meet local clinical needs while also contributing to global research and development [1] Group 1: Local Innovation Impact - Fosun Pharma's CAR-T product, Yikaida, has treated over 1,000 lymphoma patients across 190 treatment centers in 29 provinces, demonstrating the local practice's role in enhancing global accessibility of CAR-T therapies [2] - The Marie upright particle therapy system is a significant innovation that reduces the treatment room size from 120 square meters to 30 square meters, making it more adaptable to existing hospital spaces [1] Group 2: Global Collaboration and Development - The Da Vinci surgical robot has evolved from being merely imported equipment to creating a surgical robot ecosystem in China, reflecting a high-quality development phase for the domestic surgical robot industry [2] - Over 15,000 medical professionals have been trained in the use of the Da Vinci robot, with their experiences feeding back into global technological upgrades [2] Group 3: Future Directions - Fosun Pharma aims to promote the local implementation of innovative technologies to provide better treatment options for cancer patients in China [1] - The company emphasizes that open collaboration is essential for accelerating innovation, positioning China as a significant opportunity for global development [2]